Cannabis Companies Gain R&D Tax Credit Access Under Rescheduling

Rescheduling Opens IRC §41 Credit Eligibility

Cannabis operators can now claim the federal R&D tax credit under IRC §41, a benefit previously foreclosed by §280E's blanket disallowance of deductions for trafficking in Schedule I or II substances. Attorneys Meeren Amin, William Bogot, and Douglas W. Charnas of Fox Rothschild LLP say the rescheduling to Schedule III removes the statutory bar that prohibited cannabis companies from claiming any federal business deductions, including credits tied to qualified research expenditures.

IRC §280E applies only to trades or businesses trafficking in controlled substances listed in Schedule I or II of the Controlled Substances Act. Marijuana now sits in Schedule III. The disallowance no longer applies. Cannabis companies engaged in qualifying research activities can claim the §41 credit against their federal tax liability, provided they meet the statute's technical requirements.

The §41 credit covers wages, supplies, and contract research expenses incurred in developing new or improved products, processes, techniques, formulas, or software. Qualifying activities for cannabis companies include strain development, extraction method refinement, potency optimization, and formulation research for medicinal applications. The credit equals 20 percent of qualified research expenses above a base amount, or 14 percent under the alternative simplified credit method.

Compliance Requirements and Documentation Standards

Cannabis companies must satisfy IRC §41's four-part test to claim the credit: the research must rely on hard sciences, aim to eliminate technical uncertainty, follow a process of experimentation, and serve a permitted business purpose. The IRS applies this test strictly. Companies can't claim the credit for routine quality control, cosmetic product changes, or research conducted after commercial production begins.

Documentation is the operational bottleneck. The IRS requires contemporaneous records proving that research activities occurred, that qualified individuals performed the work, and that expenses tie directly to qualifying projects. Cannabis operators must maintain project logs, employee timesheets, expense receipts, and technical documentation showing the elimination of uncertainty. Retroactive reconstruction of research activities rarely survives audit.

Contract research poses additional complexity. If a cannabis company pays an outside lab or research firm to conduct qualifying work, the credit calculation depends on whether the arrangement qualifies as a funded research agreement. Under IRC §41(b)(3), the company can claim 65 percent of amounts paid to qualified research organizations, but only if the contract meets specific statutory criteria. Get the classification wrong and the IRS disallows the claim.

State-Level Credits and Interaction with Federal Rules

Several states offer parallel R&D tax credits that cannabis companies can now pursue alongside the federal §41 credit, though state-level eligibility rules vary and some jurisdictions impose additional restrictions on cannabis-related claims. California provides a research credit equal to 15 percent of qualified research expenses or 24 percent under the alternative incremental credit method, but the state's conformity to federal tax law creates ambiguity about whether cannabis companies could claim the credit even before rescheduling.

For a full breakdown of how rescheduling affects cannabis tax treatment across federal and state jurisdictions, see the CannIntel topic hub on cannabis rescheduling tax implications. The interaction between federal rescheduling and state tax codes remains unsettled in several jurisdictions, particularly where state statutes reference the federal Controlled Substances Act scheduling system.

Cannabis companies operating in multiple states must evaluate each jurisdiction's credit eligibility rules separately. Some states impose caps on total credit amounts, require pre-certification of research projects, or limit the credit to specific industries. Others allow unused credits to carry forward for up to 20 years, creating long-term tax planning opportunities for companies with net operating losses.

The next compliance deadline: cannabis companies must file amended returns within three years of the original filing date to claim retroactive credits for tax years in which rescheduling applies. The IRS hasn't issued formal guidance on whether rescheduling triggers a lookback period or applies prospectively only.